Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic.
Mov Disord
; 35(10): 1701-1711, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-726315
ABSTRACT
BACKGROUND:
The COVID-19 pandemic restricted usual healthcare management for movement-disorders patients, with a consequent upsurge in telemedicine to bridge the gap.OBJECTIVE:
To assess global telemedicine usage in the context of the pandemic.METHODS:
The Movement Disorder Society (MDS) Telemedicine Study Group surveyed telemedicine experts from 40 countries across all continents in March-April 2020. Four domains of telemedicine were assessed legal regulations, reimbursement, clinical use, and barriers; comparing emerging responses to the pandemic versus the baseline scenario.RESULTS:
All forms of telemedicine for movement disorders increased globally, irrespective of country income categorization, as an immediate response to the pandemic. This was aided by widespread availability of technology and updated government regulations. However, privacy concerns, lack of reimbursement, limited access, and lack of telemedicine training were barriers highlighted worldwide.CONCLUSIONS:
Questions remain about the longevity and extent of changes in regulations and reimbursement regarding telemedicine in the aftermath of the pandemic. © 2020 International Parkinson and Movement Disorder Society.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Reimbursement Mechanisms
/
Telemedicine
/
Coronavirus Infections
/
Pandemics
/
Movement Disorders
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Mov Disord
Journal subject:
Neurology
Year:
2020
Document Type:
Article
Affiliation country:
Mds.28284
Similar
MEDLINE
...
LILACS
LIS